Paul Muntner Selected Research

Biomarkers (Surrogate Marker)

12/2019	Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.
1/2018	Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study.
1/2017	Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms?
1/2016	Do glycemic marker levels vary by race? Differing results from a cross-sectional analysis of individuals with and without diagnosed diabetes.
11/2015	Mechanisms Influencing Circadian Blood Pressure Patterns Among Individuals with HIV.
12/2014	Republished: The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis.
7/2014	The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis.
4/2013	Relation between leukocyte telomere length and incident coronary heart disease events (from the 1995 Canadian Nova Scotia Health Survey).
8/2009	The association of biomarkers of iron status with peripheral arterial disease in US adults.
4/2008	Overweight, obesity, and elevated serum cystatin C levels in adults in the United States.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Muntner Research Topics

Disease

140	Hypertension (High Blood Pressure) 04/2024 - 04/2002
70	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 03/2002
64	Stroke (Strokes) 05/2024 - 05/2006
51	Myocardial Infarction 03/2024 - 05/2006
47	Chronic Renal Insufficiency 05/2024 - 02/2003
39	Coronary Disease (Coronary Heart Disease) 01/2022 - 09/2006
23	Diabetes Mellitus 11/2019 - 05/2006
22	Albuminuria 01/2021 - 07/2008
17	Obesity 04/2024 - 04/2008
15	Atherosclerosis 02/2024 - 09/2004
14	Masked Hypertension 01/2022 - 06/2013
13	Chronic Kidney Failure (Chronic Renal Failure) 10/2018 - 12/2003
11	Inflammation (Inflammations) 07/2023 - 10/2004
11	Heart Failure 01/2022 - 04/2009
9	Overweight 04/2024 - 01/2004
9	Kidney Diseases (Kidney Disease) 01/2021 - 04/2004
8	Ischemic Stroke 07/2023 - 07/2014
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2017 - 02/2004
7	Renal Insufficiency (Renal Failure) 07/2023 - 03/2002
7	Isolated Systolic Hypertension 01/2021 - 01/2005
7	Insulin Resistance 11/2015 - 02/2003
6	Neoplasms (Cancer) 03/2024 - 02/2009
6	Proteinuria 11/2023 - 01/2011
6	Peripheral Arterial Disease 01/2022 - 08/2005
6	Rheumatoid Arthritis 01/2019 - 10/2012
5	Anemia 07/2013 - 06/2002
4	Vascular Diseases (Vascular Disease) 01/2023 - 01/2014
4	Osteoporosis 01/2023 - 05/2012
4	Hyperuricemia 01/2023 - 09/2008
4	Wounds and Injuries (Trauma) 12/2022 - 01/2016
4	White Coat Hypertension 11/2021 - 04/2017
4	Hypercholesterolemia 01/2021 - 07/2004
4	Abdominal Obesity 06/2017 - 02/2004
4	Prehypertension 01/2017 - 06/2015
4	Weight Loss (Weight Reduction) 06/2014 - 01/2004
4	Atherosclerotic Plaque (Atheroma) 05/2013 - 09/2008
4	Hemorrhage 01/2012 - 09/2008
3	Prediabetic State (Prediabetes) 04/2024 - 09/2012
3	Hyperlipidemias (Hyperlipidemia) 01/2023 - 07/2004
3	Cognitive Dysfunction 01/2023 - 05/2013
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2017
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022 - 12/2013
3	Rhabdomyolysis 12/2018 - 10/2016
3	Infections 01/2018 - 06/2010
3	Atrial Fibrillation 08/2017 - 06/2015
3	Hypotension (Low Blood Pressure) 04/2017 - 02/2004
3	Acute Kidney Injury (Acute Renal Failure) 04/2017 - 12/2003
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2016 - 01/2009
3	Dyslipidemias (Dyslipidemia) 03/2015 - 12/2003

Drug/Important Bio-Agent (IBA)

135	Antihypertensive Agents (Antihypertensives)IBA 05/2024 - 04/2002
67	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 09/2010
45	CreatinineIBA 11/2023 - 03/2002
40	AlbuminsIBA 11/2023 - 02/2004
31	LipidsIBA 04/2024 - 01/2007
25	LDL CholesterolIBA 04/2024 - 05/2006
20	CholesterolIBA 04/2023 - 07/2004
19	HDL CholesterolIBA 01/2023 - 02/2004
18	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2003
16	C-Reactive ProteinIBA 07/2023 - 06/2003
14	Ezetimibe (Zetia)FDA Link 04/2024 - 10/2015
14	oxidized low density lipoproteinIBA 01/2023 - 05/2013
10	Proprotein Convertase 9IBA 04/2024 - 01/2015
10	Triglycerides (Triacylglycerol)IBA 01/2023 - 02/2004
10	Biomarkers (Surrogate Marker)IBA 12/2019 - 04/2008
9	Uric Acid (Urate)IBA 01/2023 - 12/2004
9	SodiumIBA 01/2022 - 01/2004
9	Cystatin CIBA 10/2018 - 04/2008
8	DiureticsIBA 01/2023 - 09/2008
7	mahuang-tangIBA 01/2022 - 06/2013
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 03/2010
7	Hemoglobins (Hemoglobin)IBA 12/2019 - 06/2002
7	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2018 - 01/2018
6	LDL Lipoproteins (beta Lipoproteins)IBA 01/2015 - 05/2006
5	Lipoprotein(a)IBA 07/2023 - 01/2004
5	Angiotensin Receptor AntagonistsIBA 01/2021 - 03/2010
5	ThiazidesIBA 11/2020 - 04/2009
5	Phosphorus (Red Phosphorus)IBA 01/2019 - 01/2009
5	PotassiumIBA 10/2018 - 10/2011
4	ORALIT (ORS)IBA 01/2023 - 09/2010
4	Insulin (Novolin)FDA Link 12/2022 - 02/2003
4	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 01/2022 - 11/2015
4	HDL LipoproteinsIBA 12/2014 - 04/2007
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2014 - 01/2010
4	MineralsIBA 01/2009 - 06/2007
4	Fibrinogen (Factor I)FDA Link 12/2004 - 06/2003
3	perindopril drug combination indapamideIBA 01/2023 - 01/2017
3	Gliclazide (Diamicron)IBA 01/2023 - 01/2017
3	Opioid Analgesics (Opioids)IBA 10/2021 - 06/2015
3	Antirheumatic Agents (DMARD)IBA 01/2019 - 10/2012
3	Dietary PotassiumIBA 12/2018 - 10/2011
3	Dietary SodiumIBA 12/2018 - 10/2011
3	Hypolipidemic Agents (Antihyperlipidemics)IBA 12/2018 - 10/2016
3	HomocysteineIBA 02/2015 - 06/2003
3	Vitamin D FDA LinkGeneric 01/2015 - 01/2009

Therapy/Procedure

50	Therapeutics 02/2024 - 07/2003
6	Polypharmacy 01/2021 - 05/2013
5	Dietary Approaches To Stop Hypertension 01/2022 - 02/2013
3	Secondary Prevention 01/2018 - 08/2004
3	Ambulatory Care (Outpatient Care) 04/2017 - 03/2014
3	Percutaneous Coronary Intervention 12/2016 - 06/2009